RELATE study: Increased ranibizumab, laser yield minimal benefits

BOSTON — An increased dose of ranibizumab offered no added benefit in eyes with retinal vein occlusion, according to a study presented here.Additionally, laser photocoagulation did not improve vision or reduce edema significantly more than ranibizumab, Peter A. Campochiaro, MD, said at Macula 2015.

Full Story →